Safety and tolerability of zoster vaccine in adults ≥60 years old

Objective To evaluate the general safety of zoster vaccine (ZV) in adults ≥60 years old. Patients/Methods Subjects were enrolled in a 1:1 ratio to receive 1 dose of ZV or placebo. Subjects were followed for serious adverse experiences (SAEs) for 42 days (primary follow-up period) and 182 days (secon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Murray, Alexander V., Reisinger, Keith S., Kerzner, Boris, Stek, Jon E., Sausser, Timothy A., Xu, Jin, Wang, William W., Chan, Ivan S.F., Annunziato, Paula W., Parrino, Janie
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2011
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3323493/
https://ncbi.nlm.nih.gov/pubmed/22048110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.7.11.17982
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados